570 related articles for article (PubMed ID: 30606201)
1. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ibrahim ME
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201
[TBL] [Abstract][Full Text] [Related]
2. Acinetobacter baumannii: A multidrug-resistant pathogen, has emerged in Saudi Arabia.
Aldali JA
Saudi Med J; 2023 Aug; 44(8):732-744. PubMed ID: 37582561
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia.
Aljindan R; Bukharie H; Alomar A; Abdalhamid B
J Med Microbiol; 2015 Apr; 64(Pt 4):400-406. PubMed ID: 25657302
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.
Aly MM; Abu Alsoud NM; Elrobh MS; Al Johani SM; Balkhy HH
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1759-1766. PubMed ID: 27527351
[TBL] [Abstract][Full Text] [Related]
6. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
8. High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia.
Alsultan AA; Evans BA; Elsayed EA; Al-Thawadi SI; Al-Taher AY; Amyes SGB; Al-Dughaym AM; Hamouda A
J Med Microbiol; 2013 Jun; 62(Pt 6):885-888. PubMed ID: 23518655
[TBL] [Abstract][Full Text] [Related]
9. Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Salehi B; Ghalavand Z; Mohammadzadeh M; Maleki DT; Kodori M; Kadkhoda H
J Appl Microbiol; 2019 Nov; 127(5):1421-1429. PubMed ID: 31400237
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of
Shah MW; Yasir M; Farman M; Jiman-Fatani AA; Almasaudi SB; Alawi M; El-Hossary D; Azhar EI
Microb Drug Resist; 2019 Nov; 25(9):1297-1305. PubMed ID: 31216221
[No Abstract] [Full Text] [Related]
11. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
Hasan B; Perveen K; Olsen B; Zahra R
J Med Microbiol; 2014 Jan; 63(Pt 1):50-55. PubMed ID: 24085817
[TBL] [Abstract][Full Text] [Related]
12. Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia.
Abdalhamid B; Hassan H; Itbaileh A; Shorman M
New Microbiol; 2014 Jan; 37(1):65-73. PubMed ID: 24531172
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
14. Detection of bla
El-Mahdy TS; Al-Agamy MH; Al-Qahtani AA; Shibl AM
Microb Drug Resist; 2017 Jan; 23(1):115-121. PubMed ID: 27183378
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.
Raible KM; Sen B; Law N; Bias TE; Emery CL; Ehrlich GD; Joshi SG
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):75. PubMed ID: 29145853
[TBL] [Abstract][Full Text] [Related]
16. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
[TBL] [Abstract][Full Text] [Related]
17. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
18. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
[TBL] [Abstract][Full Text] [Related]
19. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
[TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
